Search
Site results
- New Guidance for Treatment Switching in Oncology Drug Trials
Green Park Collaborative Releases Best Practices for Ensuring Validity When Trial Patients Change… - CMTP Receives Funding Award for Project on Clinician Engagement in Research
A team at CMTP has been approved for a $250,000 funding award through the Eugene Washington PCORI… - GPC to Host Forum on Payer Policies for Liquid Biopsy & Emerging Clinical Genomics
The Green Park Collaborative (GPC) will host a Genomics Technology Policy Forum November 2 and 3… - Maryland Commerce Convenes Partners to Form Centers of Excellence in Biomanufacturing, Transformative Medicine
Johns Hopkins University, University of Maryland, Baltimore and University of Maryland, College… - Study Seeks Women’s Insights on What Works Best for Uterine Fibroids
Duke University has announced the launch of a new registry that will enroll over 10,000 women… - GPC Genomic Databases Initiative Addresses Recommendations of Academy’s Biomarkers Report
A new report from the National Academies of Sciences, Engineering, and Medicine aims to reduce… - Real World Evidence
- GPC and MED-C Launch Joint Effort to Harmonize Standards for NGS Registries and Databases
GPC and the MED-C are launching a joint effort to advance personalized medicine by harmonizing… - Advisory Committee
Carmella Bocchino, RN, MBA America's Health Insurance Plans Ethan Basch, MD, MSc … - GPC Hosts Webinar: Initial Medical Policy and Model Coverage Guidelines for Clinical Next Generation
GPC to host free webinar Tuesday, November 24, 2015. - Alzheimer’s Disease EGD
CMTP worked with the GPC International to develop an Evidence Guidance Document (EGD) on… - Oncology MDX Testing
While molecular diagnostics offer tremendous promise for improving health and offsetting costs in… - Diabetes Late Phase Drug Studies
Published in July 2014, this EGD provides guidance for improving the design, conduct, and… - Clinical Genomics
- Published Recommendations
Recent GPC projects that are now heading toward dissemination and uptake. … - GPC Issues Initial Guidelines for Health Insurance Coverage of NGS Testing in Oncology
Multi-stakeholder group recommends coverage for NGS panels of 5-50 genomes to advance… - Next Gen Sequencing Phase I
- Treatment Switching
- Place in Therapy
- Metastatic Cancer Research Studies Should Better Evaluate and Communicate Quality of Life Measures
New report from Green Park Collaborative urges new metrics for assessing treatments for advanced… - Use Reimbursement Science to Improve Coverage Decisions by Sean Tunis
- Collaborators
GPC collaborates on its work with a diverse mix of payers, life sciences companies,… - Current Initiatives
GPC has a number of projects underway focused on improving clinical evidence. This… - Overview
- Green Park Collaborative
The Green Park Collaborative (GPC) works to improve clinical research by… - Scientific Advice
CMTP provides scientific advice to device and diagnostics companies to assist them in refining… - CMTP Awarded Grant from Edwards Lifesciences Foundation to Accelerate Adoption of Surgical Recovery Protocols in U.S. Hospitals
CMTP forming Partnership for Enhanced Recovery to promote broader adoption of proven protocols… - GPC Update: July NGS Meeting Summary
- GPC to Discuss Comparative Effectiveness and Value of Weight Loss Treatments
The GPC Endocrine-Metabolic Consortium will host a workshop this January to discuss comparative… - CMTP Releases White Paper on Advancing Enhanced Recovery for Surgical Patients
- CMTP Announces New Hires, Open Positions
- BioMaryland, DHMH and CMTP Partner offer $1M to Advance Projects which Improve Patient Outcomes and Reduce Costs
- Hepatitis C Drugs - Evidence to Demonstrate Effectiveness & Value
Please Note: Disclaimer for David Ross (U.S. Dept. Veterans Affairs): The… - PCORI Engagement Awards Program Offers CMTP Meeting Funding Support
Funding Opportunity to Facilitate Events that Advance Patient-Centered Outcomes Research… - Webinars
July 7, 2014: Hepatitis C Drugs - Evidence to Demonstrate Effectiveness and Value (click… - CMTP Issues Recommendations for Late Phase Drug Studies in Type 2 Diabetes
CMTP has issued an Effectiveness Guidance Document (EGD) for Recommendations for Late Phase Drug… - NIH Workshop on the Enrollment and Retention of Participants in NIH-funded Clinical Trials
- CMTP Announces Promotions, New Management Structure
Donna Messner and Els Houtsmuller to join executive team; Ellen Tambor and Chris Kamphaus also… - GPC & ICER Host Web Conference: Hepatitis C Drugs –Evidence to Demonstrate Effectiveness and Value
Registration is now closed for the July 7 web conference. - CMTP Hosts Stakeholder Forum on Enhanced Recovery Protocols for Surgical Patients
CMTP hosted a multi-stakeholder dialogue about the challenges and opportunities to accelerate… - Annual Meeting 2015
- Eleanor Perfetto Joins CMTP Board of Directors
Dr. Eleanor Perfetto, a Professor of Pharmaceutical Health Services Research, at the University… - Sean Tunis Testifies for House Subcommittee Hearing on "21st Century Cures: The PCAST Report on Drug Innovation"
Sean Tunis provided testimony to the US House of Representatives Energy and Commerce Subcommittee… - Nearly 100 Thought Leaders in Oncology and Endocrine-Metabolic Diseases Consider Study Design Guidance in Key Clinical Areas
The Green Park Collaborative (GPC-USA), a multi-stakeholder forum of the Center for Medical… - If You Cure It, Will They Pay? Placing a Value on Lives
Sean Tunis spoke at the Milken Institute Global Conference, during the panel discussion "If you… - Stakeholder Engagement
The process of actively eliciting input from the full range of stakeholders throughout the many… - Pragmatic Clinical Trials
These randomized controlled trials are designed to evaluate the risks, benefits and costs of… - patient centered outcomes research
Patient Centered Outcomes Research (PCOR) is research that provides patients and their… - comparative effectiveness research
Comparative Effectiveness Research, often called CER, is the generation and synthesis of… - Rethinking Spine Care
Sean Tunis was quoted in this Modern Healthcare article exploring how the rapid growth of spinal… - Debating the Evidence of Pharmacogenetic Testing
Pat Deverka, MD, MS participated in a debate entitled “Debating About the Evidence for Clinical… - Funding Sources
Abbott Labratories AcademyHealth Aetna Foundation Agency for Healthcare Research… - Stakeholder Defined Research
Pat Deverka gave this presentation as part of EPG Grand Rounds at the University of Maryland.… - CMTP to Develop Guidelines for Clinical Utility Evidence for NGS-based Cancer Tests
GenomeWeb.com's Clinical Sequencing News reported on the GPC efforts to develop guidelines for… - PCORnet PPRN Partner Meeting
CMTP was an active partner at this workshop hosted by PCORI for its Patient-Powered Research… - PCORnet Kickoff Meeting
This January 2014 event launched the development of a clinical research network aimed at… - GPC to Develop Evidence Standards for Next Generation Sequencing-Based Testing in Oncology
The Green Park Collaborative (GPC-USA), sponsored by the Center for Medical Technology Policy… - CMTP Names Elisabeth Houtsmuller to Lead Green Park Collaborative
Baltimore, MD – The Center for Medical Technology Policy (CMTP) has announced the selection of… - Evaluation of Clinical Validity and Clinical Utility of Actionable Molecular Diagnostics in Adult Oncology
Pat Deverka, MD, MS, gave this presentation at the inaugural meeting of the Green Park… - Collaborators
GPC-USA includes a diverse mix of payers, life sciences companies, patients, clinicians, and… - New Consortia in Oncology and Metabolic Diseases Launch Efforts to Develop Methodological Standards to Guide Reimbursement Decisions
Green Park Collaborative-USA’s inaugural annual meeting gathers nearly 100 health care leaders… - Green Park Collaborative Annual Meeting Presentation
These slides were shared at the Green Park Collaborative Annual Meeting in November 2013. This… - Learning Health Care System
What is a Learning Health Care System? A learning health care system is one in which everyday… - Electronic Consent: a Discussion of eConsent Ethical and Regulatory Considerations and the IRB Review Process
Donna Messner participated in this presentation at the 2013 Advancing Ethical Conference. Her… - Volunteer for a working group
One of the key aspects of comparative effectiveness research is stakeholder engagement in the… - CMTP Joins Major PCORI-Supported Initiatives on CER, Stakeholder Engagement
CMTP received two awards as part of recent PCORI funding of the first National Patient-Centered… - Coverage with Evidence Development
When developing a new drug or technology, researchers focus on getting the evidence they need… - Effectiveness Guidance Documents
Our goal in developing Effectiveness Guidance Documents (EGDs) is to create transparent,… - Pragmatic Clinical Trials
Pragmatic Clinical Trials (PCTs) are designed to evaluate the risks and benefits of health… - Thank You
You will be added to our mailing list and receive the next newsletter. - Sign Up
Sign up to receive the latest insights from CMTP in your inbox. - Newsletters
Current Issue: Fall 2016 Previous Issues: December 2015… - Stakeholder Engagement
CMTP seeks to improve the quality, relevance, and efficiency of clinical research by engaging key… - Thank You
Somebody will contact you shortly to answer your questions or provide you with more… - Contact Us
- Streamlined Informed Consent
Every day, physicians make care decisions for their patients, often choosing from an array of… - NIH Collaboratory
Leaders conducting pragmatic trials across multiple healthcare systems often face regulatory… - Green Park Collaborative
(function(d){ var js, id="pikto-embed-js",… - Featured Projects
CMTP is excited to be an active partner in numerous projects that are at the forefront of… - Transforming Clinical Research
Thanks to new technologies and the increasing use of electronic medical records, the health… - Shaping Health Policy Solutions
The FDA generally requires a demonstration of safety and efficacy before new pharmaceuticals… - Our Work
- Providing Methodological Guidance
Intensifying cost pressures and new models of shared risk (e.g., Accountable Care… - NIH Collaboratory Stakeholder Advisory Group
CMTP is leading the Stakeholder Engagement Core for the NIH Collaboratory and has formed a… - Quintiles Receives PCORI Funding Award for Comparing Effectiveness of Uterine Fibroid Treatments in Real-World Practice
The Patient-Centered Outcomes Research Institute (PCORI) awards research funding to Quintiles to… - Sean Tunis on BioCentury TV
Dr. Sean Tunis, President & CEO of the Center for Medical Technology Policy will appear on… - CMTP Issues Guidance for Clinical Utility Studies of Molecular Diagnostics in Oncology
- CMTP Announces Formation of Green Park Collaborative to Promote Innovation and Effectiveness of New
- Overview of Green Park Collaborative
This presentation from the inaugural meeting of the Green Park Collaborative provides an overview… - Establishing Work Priorities for GPC-USA
Penny Mohr and Sean Tunis gave this presentation at the Inaugural Green Park Collaborative… - Effectiveness Guidance Document on Alzheimer’s Disease
- Experts Aim to Redefine Healthcare and Research Ethics
- Experts Aim to Redefine Healthcare and Research Ethics
Healthcare experts hope to establish a new learning healthcare system that will implement a new… - CMTP & ISOQOL Host Webinar: Incorporating Patient-Reported Outcomes
CMTP and ISOQOL will host a webinar on incorporating patient-reported outcomes and comparative… - CMTP Convenes Workshop on Comparative Effectiveness Research in Diabetes
The CMTP workshop will address ways to improve the quality of comparative effectiveness research… - Careers
Impact: We are committed to creating measurable change and making a positive difference by… - Our Team
Leadership Sean Tunis, MD, MSc Founder, President, and Chief Executive Officer 410.547.2687 ext… - Strategic Overview
Our Vision A health care system where patients, clinicians, health care policymakers, and… - About Us
The Center for Medical Technology Policy (CMTP) is an independent… - Bending the Cost Curve Through Comparative Effectiveness Research
Sean Tunis gave this presentation at ASCO 2012. It summarizes how CER can help provide better… - RobConley, MD, JD, MPH
Research Manager - EleanorPerfetto, PhD, MS
Senior Vice President - Ellen Tambor, MA
Research Director - Nora Osowski, MPH
Research Manager - Rachael Moloney, MHS
Research Manager - Chris Kamphaus, MSA
Controller - Julie Simmons, CMP
Manager, Marketing & Communications - Peter Mazonson, MD, MBA
Co-Founder & Chief Executive Officer - Mark Gibson
Co-Founder, Co-Director - Pamela Wescott, MPP
Director, Patient Perspectives - Jennifer Sweeney, MA
Director, Consumer Engagement and Community Outreach - Sandra Puczynski, PhD
Associate for Research - Connie Hofmann
- DonnaCryer, JD
Chief Executive Officer - Lawrence Sadwin
Chairman - Janelle King
Executive Assistant - Jennifer Al Naber, MS
Project Manager, Green Park Collaborative - Donna A. Messner, PhD
Senior Vice President - PennyMohr, MA
Senior Vice President, Program Development - StuartSpector, MBA
Chief Operating Officer, Metro DC/Chesapeake Market - SeanTunis, MD, MSc
Founder & Chief Executive Officer
100 results match your search for "":
CMTP Team Results
21 team members match your search for "":
Resource Center results
- New Guidance for Treatment Switching in Oncology Drug Trials
GPC released a report that provides guidance for researchers who lead oncology drug trials that may… - Methods for Evaluating the Comparative Effectiveness of Interventions for Obesity and Overweight
Summary of January 2015 Workshop - Webinar: Initial Medical Policy and Model Coverage Guidelines
November 24, 2015, the Green Park Collaborative (GPC) hosted a webinar on policies for Next… - NGS In Clinical Oncology: Phase 2 Overview
Following the issuance of initial guidelines for NGS coverage in August 2015, GPC-USA is embarking… - Initial Medical Policy and Model Coverage Guidelines for Clinical NGS in Oncology
The Green Park Collaborative has issued initial Guidelines for Health Insurance Coverage of Next… - Highlights of the 2015 Annual GPC Meeting
The Green Park Collaborative convened its 2015 Annual Meeting April 30, 2015. Here are highlights… - Payer perspective on future acceptability of comparative effectiveness and relative effectiveness re
Moloney R, Mohr P, Hawe E, Shah K, Garau M, Towse A. Payer perspective on future acceptability of… - Medical and pharmacy coverage decision making at the population level
Mohr PE, Tunis SR. Medical and pharmacy coverage decision making at the population level. J.… - Recommendations for Comparing Cancer Therapy Sequences
This EGD provides recommendations to use real-world data sources in studies to compare sequences of… - Understanding the role and evidence expectations of health technology assessment and coverage/payer
Henshall C, Sanson L, Eichler H-G, Lemgruber A, Longson C, O’Rourke B, Tunis S. Understanding… - The views of quality improvement professionals and comparative effectiveness researchers on ethics,
Whicher D, Kass N, Saghai Y, Faden R, Tunis S, Pronovost P. The views of quality improvement… - Green Park Collaborative Annual Progress Report 2015
This report shows the Green Park Collaborative's 2015 accomplishments, as well as upcoming… - Futurescapes: Evidence expectations in Europe for comparative effectiveness research for drugs in 20
Towse A, Garau M, Mohr P, Messner DA. Futurescapes: Evidence expectations in Europe for comparative… - Futurescapes: Evidence expectations in the USA for comparative effectiveness research for drugs in 2
Messner DA, Mohr PE, Towse A. Futurescapes: Evidence expectations in the USA for comparative… - The future of comparative effectiveness and relative efficacy of drugs: an international perspective
Messner DA, Mohr PE, Garau M. The future of comparative effectiveness and relative efficacy of… - From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new
Eichler H-G, Baird LG, Barker R, … Tunis SR, et al. From adaptive licensing to adaptive pathways:… - Reimbursing NGS Testing. Clinical OMICs – Molecular diagnostics in personalized medicine
Tunis S. Reimbursing NGS Testing. Clinical OMICs – Molecular diagnostics in personalized… - Demonstrating the Clinical Utility of Next Generation Sequencing in Clinical Oncology
The Green Park Collaborative convened a multi-stakeholder meeting July 7, 2014 to discuss the… - What can comparative effectiveness research contribute to integrative health in international perspe
Witt C, Withers SR, Grant S, Lauer M, Tunis SR, Berman B. What can comparative effectiveness… - A Multi-stakeholder Agenda to Advance Enhanced Recovery for U.S. Surgical Patients
This white paper builds upon earlier work, including a multi-stakeholder forum in which… - Hepatitis C Drugs - Evidence to Demonstrate Effectiveness and Value
On July 7, 2014, the Green Park Collaborative (GPC) of the Center for Medical Technology Policy… - exCERpts July 2014
This is the July 2014 CMTP newsletter - Enhanced Recovery Meeting Summary
June 10, 2014, with initial support from Edwards Life Sciences, CMTP hosted a multi-stakeholder… - Accelerated access to innovative medicines for patients in need
Baird LG, Banken R, Eichler H-G, Kristensen FB, Lee DK, Lim JCW, Lim R, Longson C, Pezalla E,… - Recommendations for Late Phase Drug Studies in Type 2 Diabetes
The EGD provides guidance for improving the design, conduct, and reporting of late phase (approval… - EGD Process Document
Information is provided on the general process for developing EGDs, and the resulting products… - exCERpts May 2014
This is the May 2014 CMTP newsletter. - Green Park Collaborative-USA Annual Progress Report 2013-2014
This report highlights the Green Park Collaborative-USA's year one accomplishments, as well as… - Current Drug Development Paradigm
Pharmaceutical companies face rapidly evolving regulatory and reimbursement evidentiary… - Debating the Evidence of Pharmacogenetic Testing
Pat Deverka, MD, MS participated in a 6 member debate entitled “DEBATING ABOUT THE EVIDENCE FOR… - exCERpts February 2014
This is the Feburary 2014 CMTP newsletter. - Green Park Collaborative-USA Overview (2014)
This overview provides background on the purpose, structure, and expected outcomes of GPC-USA… - Stakeholder-Defined Research
This is a presentation given by Pat Deverka as part of EPG Grand Rounds, at the University of… - Payer Perspectives Usability Healthcare Products
Bridging the Gap Between Information Needs and Evidence Translation. This report, produced for… - PCORnet PPRN Partner Meeting
A workshop hosted by PCORI for its Patient-Powered Research Network (PPRN) partners. The goal of… - PCORnet
On January 21 and 22, 2014, the Engelberg Center for Healthcare Reform at the Brookings Institution… - Early Pharmaceutical Pragmatic Clinical Trials
A white paper on the historical context for a discussion about pragmatic clinical trials and their… - Endocrine Metabolic Consortium Overview
As part of GPC-USA, the Endocrine-Metabolic Consortium will develop methodological standards for… - COMET Initiative
This presentation was part of the GPC-USA 2013 Annual Meeting - GPC Annual Meeting Introduction
This is the first session of the GPC-USA 2013 Annual Meeting. - Evidence Gaps in NGS Tests
This panel discussion reviewed the evidence gaps affecting clinical use of next generation… - Oncology Consortium Update
Progress Update on the GPC-USA Oncology Consortium presented at the 2014 Annual Meeting by Donna… - EMC Progress
Update on GPC-USA Endocrine-Metabolic Consortium provided at November 2013 Annual Meeting by Nisa… - GPC-USA Annual Meeting Presentations Nov 13
This presentation by Sean Tunis provides an update on the first six months of GPC-USA. - Electronic Consent: Discussion eConsent Ethical and Regulatory Considerations,
Donna Messner participated in this presentation at the 2013 Advancing Ethical Conference. Her… - Oncology Overview (2013)
Part of GPC-USA, the Oncology Consortium will develop methodological standards for research… - exCERpts November 2013
This is the November 2013 CMTP newsletter. - Recommendations from the EGAPP Working Group: does PCA3 testing for the diagnosis and management of
Calonge N, Klein RD, Berg JS, et al. Recommendations from the EGAPP Working Group: does PCA3… - Bariatric Surgery CED
This framework, currently under development, will allow for reimbursement of clinical costs for… - Methodological recommendations for comparative research on the treatment of chronic wounds.
Sonnad SS, Goldsack JC, Mohr P, Tunis S. J Wound Care. 2013 Sep;22(9):470-80. PMID: 24005781… - Medicare policy on bariatric surgery: decision making in the face of uncertainty
Tunis SR, Messner DA. Medicare policy on bariatric surgery: decision making in the face of… - Recommendations for the Design of Phase 3 Pharmaceutical Trials
Sonnad SS, Mullins CD, Whicher D, Goldsak J, Mohr PE, Tunis SR. Contem Clin Trials.… - Ethics and informed consent for comparative effectiveness research with prospective electronic
Faden RR, Kass, NE, Whicher DM, Stewart W, Tunis SR. Med Care. 2013;51(8 Suppl 3):S53-7. doi:… - Break a vicious cycle
Hayes DF, Allen J, Compton C, Gustavsen G, Leonard DGB, McCormack R, Newcomer L, Pothier K,… - NIH Collaboratory Stakeholder Engagement Core
Sean Tunis presented at NIH Collaboratory Grand Rounds on the first meeting of the SAG - Encouraging value-based insurance designs in state health insurance exchanges
Buttorff CA, Tunis SR, Weiner JP. Am J Manag Care. 2013;19(7):593-600. PMID: 23919422 - Performance-based risk-sharing arrangements—good practices for design, implementation, and evaluatio
Garrison LP, Towse A, Briggs A, de Pouvourville G, Grueger J, Mohr PE, Severens JL, Siviero P,… - exCERpts July 2013
This is the July 2013 CMTP newsletter. - EGD Overview
This document provides background on the purpose of EGDs, a framework for creating them, insights… - Establishing Work Priorities for GPC-USA
Penny Mohr, and Sean Tunis, MD, MSc gave this presentation at the Inaugural Green Park… - Green Park Collaborative - USA: Governance Establishment Discussion
Deloitte Consulting LLP, gave this presentation at the Inaugural meeting of the Green Park… - Evaluation of Clinical Validity and Clinical Utility of Actionable Molecular Diagnostics in Adult On
Pat Deverka, MD, MS, MBE, gave this presentation at the inaugural meeting of the Green Park… - Development of an EGD for Patient Reported Outcomes in Oncology
Ethan Basch, MD, and Amy Abernethy, MD gave this presentation at the Inaugural Green Park… - An Overview of the Green Park CollaborativeSean Tunis, MD, MSc
Sean Tunis, MD, MSc, gave this presentation at the inaugural meeting of the Green Park… - Delivering Value in Healthcare: A Multi-Stakeholder Vision
The presentation was shared at the inaugural Green Park Collaborative meeting in May 2013 - HTAi Policy Forum: Points of Relevance to GPC-USA
Chris Hensall gave this presentation at the Inaugural Green Park Collaborative meeting. - EGD on MDX
While molecular diagnostics offer tremendous promise for improving health and offsetting costs in… - Value-of-information analysis within a stakeholder-driven research prioritization process
Carlson JJ, ..., Esmail LC, Deverka PA, et al. Med Decis Making. 2013;33(4):463-471. doi:… - GPC Evaluation Report
An evaluation of the GPC's pilot project, which resulted in an EGD on the study of therapies for… - exCERpts April 2013
This is the April CMTP newsletter. - Design of Clinical Studies of Pharmacologic Therapies for Alzheimer’s Disease
This EGD on Alzheimer's disease tests a process for developing disease-specific guidance for… - Regulatory and reimbursement innovation
Lindor RA, Allocco SJ, Cheatham L, et al. Sci. Transl. Med. 2013;5(176):176cm3. doi:… - Recommendations from the EGAPP Working Group: does genomic profiling to assess type 2 diabetes risk
Evaluation of Genomic Applications in Practice Prevention Working Group. Genet Med.… - Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR path
Calonge N, Fisher NL, Berg AO, et al. Genet Med. 2013; doi: 10.1038/gim.2012.184. PMID: 23429431.… - Getting our priorities straight: a novel framework for stakeholder-informed prioritization of cancer
Esmail LC, Roth J, Deverka PA. Genet Med. 2013;15(2):115-122. doi: 10.1039/gim.2012.103. PMID:… - Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome
Veenstra DL, Piper M, Tunis SR et al. Genet Med. 2013;15(1):14-24. doi: 10.1038/gim.2012.106. PMID:… - An ethics framework for a learning health care system: A departure from traditional research ethics
Faden RR, Kass NE, Goodman SN, Pronovost P, Tunis SR, Beauchamp TL. Hastings Center Report.… - The research-treatment distinction: A problematic approach for determining which activities should h
Kass NE, Faden RR, Goodman SN, Pronovost P, Tunis SR, Beauchamp TL. Hastings Center Report.… - Stakeholder participation in comparative effectiveness research: Defining a framework for engagement
Deverka PA, Lavallee DM, Desai PJ, Esmail LC, Ramsey SD, Veenstra DL, Tunis SR. J Comp Eff Res.… - Incorporating stakeholder perspectives in developing a translation table framework for CER
Gliklich RE, Tunis SR, Mohr PE, Messner DA, Moloney RM, Karkare SU, et al. J Comp Eff Res. 2012;… - Stakeholder assessment of the evidence for cancer genomic tests: insights from three case studies
Deverka PA, Schully SD, Ishibe N, et al. Genet Med. 2012;14(7):656-662. doi: 10.1038/gim.2012.3.… - Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness
Basch E, … Spencer MR, Tunis SR, et al. J Clin Oncol. 2012;30(34);4249-4255. doi:… - Improving efficiency effectiveness pragmatic clinical trials older adults US
Saag KG, Mohr PE, Esmail L, Wright N, Curtis JR, Cutter G, Delzell E, Gary LC, Lewis CE, Harrington… - EGD on Treatment of Chronic Wounds
This EGD provides specific recommendations to product developers and clinical researchers on the… - Effectiveness guidance document (EGD) for acupuncture research
Witt CM, Aickin M, Tunis SR, et al. BMC Complement Altern Med. 2012;12(1):148. doi… - EGD on New Indications for Late Stage Oncology Treatment
This EGD provides a framework to guide the design and implementation of prospective clinical trials… - Stakeholder Engagement in Comparative Effectiveness Research
Lavallee DC, Williams CJ, Deverka PD, Tambor ES. Stakeholder engagement in comparative… - Improving CER: New methodological standards focus on quality and relevance of research to patients
Tunis SR. BMJ. 2012;345:e5160. doi: 10.1136/bmj.e5160. - EGD on Treatment of Atrial Fibrillation
This EGD outlines how future studies can improve our knowledge of atrial fibrillation by addressing… - The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research
Chalkidou K, Tunis SR, Whicher DM, Fowler R, Zwarenstein M. Clin Trials. 2012;9(4):436-446. doi:… - 2011 CER Summit Report
A summary of the 2011 CER Summit which explored the challenges and opportunities for improving… - Building the evidence base for decision making in cancer genomic medicine using CER
Goddard KA, Knaus WA, Tunis SR, et al. Genet Med. 2012;14(7):633-642. doi: 10.1038/gim.2012.16.… - Percutaneous vertebroplasty and kyphopalsty for pathologic vertabral fractures in medicare
Itagaki MW, Telenfield AD, Kwam, SW, Brunner JWM, Mortell KE, Brunner MC. J. Vasc Interv Radiol.… - Bending Cost Curve CER
During a presentation at ASCO 2012, Sean Tunis summarized how CER can help provide better… - EGD on Patient Reported Outcomes in CER and Adult Oncology
This EGD provides recommendations to set a minimum standard that will ensure that data collection… - Incorporating Stakeholder Perspectives Translation Table Framework for CER
Gliklich RE, Tunis SR, Mohr PE, Messner DA, Moloney RM, Karkare SU, et al. . J Comp Eff Res. 2012;… - Methodological Guidance for Molecular Diagnostics Research in Oncology Workshop Slides
A presentation by Sean Tunis on evidentiary standards for determining the clinical utility of… - Prioritization in comparative effectiveness research: the CANCERGEN Experience
Thariani R, Wong W, Carlson JJ, Garrison L, Deverka PA, Esmail LC, et al. Med Care.… - Three perspectives on the impact of comparative effectiveness research on decision making
Brixner D, Oderda G, Mohr PE, Dubois R, Cannon E. J Manag Care Pharm. 2012;18(4-a):s01-s17… - Continuous patient engagement in comparative effectiveness research
Mullins CD, Abdulhalim AM, Lavallee DC. JAMA. 2012;307(15):1587-1588. doi: 10.1001/jama.2012.442.…
100 resources match your search for "":